Vaccine hesitancy

CreakyJoints Presents Multistakeholder Priorities for Research in Vaccine Uptake Among Adults with Autoimmune Disease at the American College of Rheumatology Convergence 2022

Retrieved on: 
Tuesday, November 8, 2022

Thirty-three topics were narrowed down using a modified online Delphi process to thirteen topics rated as critical by at least 70 percent of stakeholders.

Key Points: 
  • Thirty-three topics were narrowed down using a modified online Delphi process to thirteen topics rated as critical by at least 70 percent of stakeholders.
  • Top topics identified for research included: vaccine effectiveness for adults with autoimmune disease, beliefs about vaccine safety among adults with autoimmune disease, and myths and misinformation about vaccines.
  • One of the 2022 accepted scientific posters, Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis, also shares patient perspectives on telemedicine delivery.
  • Scientific Posters by CreakyJoints at the ACR Convergence 2022:

A global consensus on how to end COVID-19 as a public health threat

Retrieved on: 
Thursday, November 3, 2022

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- While significant scientific and medical advances have been made in the fight against COVID-19, the virus remains a major public health threat. The global response has been fraught with challenges such as widespread misinformation about the disease and vaccines, vaccine hesitancy, and inequitable access to treatments and vaccines. Each country has responded differently, and often inadequately, revealing a worrisome lack of coordination and clear goals.

Key Points: 
  • Each country has responded differently, and often inadequately, revealing a worrisome lack of coordination and clear goals.
  • The 57 recommendations encompass six major areas to address this public health threat: communications, health systems, vaccination, prevention, treatment and care, and inequities.
  • The experts emphasize the need for significant efforts to improve health communications, rebuild public trust, combat misinformation, and engage communities directly in the management of this and future public health emergency responses.
  • "With this consensus, we make unique, practical proposals to end COVID-19 as a public health threat now and lay a solid groundwork to address large-scale outbreaks of infectious disease, reducing the burden on society, especially vulnerable populations, over time."

Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study

Retrieved on: 
Monday, October 17, 2022

PLYMOUTH MEETING, Pa., Oct. 17, 2022 /PRNewswire/ -- New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment. The researchers analyzed the frequency of side effects (also referred to as immune-related adverse events, or irAEs) in 408 patients receiving immune checkpoint inhibitor (ICI) therapy between January 16 and March 27, 2021. They found no increase in type, frequency, or severity of side effects from those receiving both immunotherapy and the vaccine at the same time.

Key Points: 
  • "This was surprising, since there is overwhelming evidence of higher risk for COVID-19-infection related complications in patients actively receiving cancer treatment.
  • More than 25,000 oncologists and other cancer care professionals across the United States readJNCCNJournal of the National Comprehensive Cancer Network.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .
  • Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.

Government of Canada invests in applied research collaborations between colleges and local partners

Retrieved on: 
Friday, October 14, 2022

That is why the Government of Canada values the tremendous contributions that colleges make as a key innovation player in Canada, offering unique knowledge, expertise, capabilities, and equipment to their applied research collaborations.

Key Points: 
  • That is why the Government of Canada values the tremendous contributions that colleges make as a key innovation player in Canada, offering unique knowledge, expertise, capabilities, and equipment to their applied research collaborations.
  • The CCI program is a key vehicle for funding applied research in Canada, strengthening research links and collaborations between Canadian colleges and partners from the private, public and not-for-profit sectors, other colleges, and/or universities with a common goal of creating economic, social, health and environmental benefits for Canada.
  • These collaborations encourage colleges to help partners address research challenges that are of importance to their communities and also applicable across Canada.
  • College students will also receive valuable training experience in essential technical skills that local businesses and community organizations seek when hiring new workers.

NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments

Retrieved on: 
Thursday, September 22, 2022

PLYMOUTH MEETING, Pa., Sept. 22, 2022 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis. This latest evidence-based, expert consensus-formulated summary on cancer and COVID-19 vaccination and prevention is available for free at NCCN.org/covid-19. Significant revisions include new recommendations for the recently-approved bivalent vaccines and advice on protecting children with cancer.

Key Points: 
  • This latest evidence-based, expert consensus-formulated summary on cancer and COVID-19 vaccination and prevention is available for free at NCCN.org/covid-19 .
  • Significant revisions include new recommendations for the recently-approved bivalent vaccines and advice on protecting children with cancer.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .
  • Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg , Instagram @NCCNorg , and Twitter @NCCN .

WHO selects PharmaJet Needle-free Injection System for Million+ Polio Vaccination Campaign

Retrieved on: 
Wednesday, August 31, 2022

Over 2.7 million children have been targeted for this program so far using the PharmaJet Tropis NFIS.

Key Points: 
  • Over 2.7 million children have been targeted for this program so far using the PharmaJet Tropis NFIS.
  • The WHO previously introduced needle-free intradermal delivery of inactivated polio vaccine (ID-IPV) using the PharmaJet Tropis NFIS in both Pakistan and Somalia for the immunization of over 3 million children.
  • The PharmaJet Tropis NFIS was selected based on its proven cost savings, ease of training and improved coverage benefits.
  • In June, WHOs thirty-second polio International Health Regulations (IHR) Emergency Committee statement , was convened by the WHO Director-General to review the progress on global eradication of polio.

Melax Tech Receives NIAID Award to Develop Real-Time Surveillance of Vaccine Misinformation from Social Media Platforms

Retrieved on: 
Wednesday, August 10, 2022

HOUSTON, Aug. 10, 2022 /PRNewswire/ --Melax Tech, a world leader in biomedical Natural Language Processing (NLP) technology, today announced the securing of a Phase One SBIR award focused on developing real-time surveillance of vaccine misinformation from social media platforms using ontology and NLP.

Key Points: 
  • HOUSTON, Aug. 10, 2022 /PRNewswire/ --Melax Tech, a world leader in biomedical Natural Language Processing (NLP) technology, today announced the securing of a Phase One SBIR award focused on developing real-time surveillance of vaccine misinformation from social media platforms using ontology and NLP.
  • Dr. Jingcheng Du, Director of NLP research at Melax Tech, noted, "A major driver for vaccine hesitancy is widespread and uncontrolled vaccine misinformation.
  • As one of its first kinds, we will build deep learning-based NLP algorithms to extract and normalize vaccine misinformation from social media.
  • Furthermore, to engage a broad community, we will develop an interactive visualization to synthesize the vaccine misinformation into a comprehensible format.

Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake

Retrieved on: 
Friday, August 5, 2022

This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.

Key Points: 
  • This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.
  • Global Impact is publishing the Full Insights Report on the first Vaccine Confidence Fund which features findings from the grantees research and insights on potential ways to drive vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

The Rockefeller Foundation Launches the Vaccination Action Network to Strengthen Health Systems and Scale Up Covid-19 Vaccinations in sub-Saharan Africa

Retrieved on: 
Tuesday, August 2, 2022

NAIROBI, Kenya, August 2, 2022 /PRNewswire/ -- The Rockefeller Foundation announces the launch of the Vaccination Action Network (VAN), a USD$7.4 million locally-led, peer-to-peer learning initiative designed to engage public health decision-makers across sub-Saharan Africa and bolster their efforts to strengthen health systems while scaling up Covid-19 vaccine demand strategies. Sabin Vaccine Institute and Dalberg are the secretariat for the network, while Amref Health Africa (Amref) is playing a key role to guide and administer subgrants to local organizations in participating countries so that they can implement vaccine demand generation strategies discussed during the learning sessions.

Key Points: 
  • "The Vaccination Action Network's community-based approach brings together our counterparts from across the region and country.
  • This collaboration is the key to finding and implementing the right vaccination approach," said Dr. Diana Atwine, Permanent Secretary, Ministry of Health, Uganda.
  • While more than 60 percent of people have been fully vaccinated against Covid-19 globally, just 20 percent of people in Africa have received full doses.
  • "The Vaccination Action Network is helping to establish new channels of communication that will consistently elevate regional learnings, solutions, and leadership," said William Asiko, Vice President of The Rockefeller Foundation Africa Regional Office.

Meridian's "Shots for Shoes" Campaign Provides New Shoes to Those Who Receive the COVID-19 Vaccine

Retrieved on: 
Tuesday, July 26, 2022

As the coronavirus and new emerging variants remain a very real threat in Michigan , people continue to test positive, and residents continue to be hospitalized.

Key Points: 
  • As the coronavirus and new emerging variants remain a very real threat in Michigan , people continue to test positive, and residents continue to be hospitalized.
  • The Centers for Disease Control and Prevention (CDC) recommends everyone ages six months and older get vaccinated against COVID-19.
  • To thank community members for getting vaccinated against COVID-19, the "Shots for Shoes" campaign will provide eligible Meridian members with a gift cardfor a new pair of shoes.
  • Meridian members ages six months or older who receive any dose of the COVID-19 vaccine (1st, 2nd, or booster) are eligible to receive a shoe store gift card from Shoe Dept.